Three is the magic number as they say… After bringing you the highlights of the first and second day of the biggest Biotech Convention worldwide, we couldn’t give up on you so close from the end. So without further ado, here’s the summary of day three.
Katrine Bosley, CEO of Editas, hosted Arnt Schottelius from MorphoSys, Loredana Ablondi, Licensing Manager of Chiesi Farmaceutici and Andre Hoekema, VP of Corporate Development at Galapagos NV. All stood on the same stage to tell the audience about their success stories. Regardless of the different background of the three firms, all representatives underlined the necessity of establishing critical alliances, essential for the growth of any company, not to mention the opportunities these alliances can bring. However, knowing when to part from your ally is just as important. On this note, Schottelius spoke about his personal experience and explained that terminating a partnership isn’t necessarily a bad thing. The termination of a partnership demonstrates the capacity of both partners to communicate with one another,